Advanz Pharma secures rights to commercialize Alvotech’s biosimilar candidate for Eylea® in Europe Advanz Pharma will leverage its existing specialty […]
Wilmington, DE, June 18, 2024 (GLOBE NEWSWIRE) — Feutune Light Acquisition Corporation (Nasdaq: FLFV), a special purpose acquisition company (“FLFV” […]